Laboratory variables’ effect on disease severity and prognosis. by Sam Alahyari (12645313)

Subjects:

Determination of lymphocyte cut-offs to differentiate between patients with Covid 19 and healthy controls. by Sam Alahyari (12645313)

Subjects:

The odds of death affected by immune cells in patients with COVID-19. by Sam Alahyari (12645313)

Subjects:

Impact of SARS‐CoV‐2 infection on T, B and NK cell numbers in patients compared with the control group (**** <i>P< 0</i>.<i>0001</i>). by Sam Alahyari (12645313)

Subjects:

The odds of severity affected by immune cells in patients with COVID-19 per 100. by Sam Alahyari (12645313)

Subjects:

Changes in LC cases and deaths in male and female from 2004 to 2018, decomposed by three population-level determinants: population aging, population growth and epidemiological chan... by Ze-Xing Zhang (18074512)

Subjects:

Model of CRC stage at diagnosis with delays to diagnosis (Australia). by Joachim Worthington (8394213)

Subjects:

Scenarios analysed. by Joachim Worthington (8394213)

Subjects:

A visual summary of the key study findings. by Joachim Worthington (8394213)

Subjects:

Fig 3 - by Joachim Worthington (8394213)

Subjects:

Post- diagnosis CRC survival model (Australia). by Joachim Worthington (8394213)

Subjects:

Model outputs used to inform this study. by Joachim Worthington (8394213)

Subjects:

Fig 4 - by Joachim Worthington (8394213)

Subjects:

Natural history of colorectal cancer, as simulated by Policy1-Bowel and OncoSim. by Joachim Worthington (8394213)

Subjects:

Summary of modelling methods—incorporating real-world data into colorectal cancer burden calculations. by Joachim Worthington (8394213)

Subjects:

Frequencies of peripheral blood immune cells with each profile in SVR and non-SVR cases. by Miyabi Miura (18605126)

Subjects:

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in global men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in Chinese men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects:

Number of follicular lymphoma cases and trends in age-adjusted rates and relative frequency of FL among the incident NHL cases according to sex for the period 2008–2017. by Yu-Chieh Su (138988)

Subjects:

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects: